Jeil Pharmaceutical Co Ltd (271980) - Total Liabilities

Latest as of September 2025: ₩258.07 Billion KRW ≈ $174.89 Million USD

Based on the latest financial reports, Jeil Pharmaceutical Co Ltd (271980) has total liabilities worth ₩258.07 Billion KRW (≈ $174.89 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Jeil Pharmaceutical Co Ltd (271980) cash flow conversion to assess how effectively this company generates cash.

Jeil Pharmaceutical Co Ltd - Total Liabilities Trend (2017–2024)

This chart illustrates how Jeil Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Jeil Pharmaceutical Co Ltd (271980) asset resilience to evaluate the company's liquid asset resilience ratio.

Jeil Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Jeil Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Chialin Precision Industrial Co Ltd TWO:3310	Taiwan	NT$4.18 Billion
Digimarc Corporation NASDAQ:DMRC	USA	$12.73 Million
D-Box Technologies Inc. TO:DBO	Canada	CA$12.85 Million
P.C.S. Machine Group Holding Public Company Limited BK:PCSGH	Thailand	฿741.11 Million
SPRINGFIELD PROP. LS-125 F:9MZ	Germany	€145.51 Million
Resources Connection Inc F:RCO	Germany	€80.85 Million
Patriot National Bancorp Inc NASDAQ:PNBK	USA	$993.16 Million
TTK Healthcare Limited NSE:TTKHLTCARE	India	Rs2.10 Billion

Liability Composition Analysis (2017–2024)

This chart breaks down Jeil Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Jeil Pharmaceutical Co Ltd market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.30	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.26	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.51	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Jeil Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Jeil Pharmaceutical Co Ltd (2017–2024)

The table below shows the annual total liabilities of Jeil Pharmaceutical Co Ltd from 2017 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩306.38 Billion ≈ $207.63 Million	-7.24%
2023-12-31	₩330.29 Billion ≈ $223.84 Million	+9.63%
2022-12-31	₩301.29 Billion ≈ $204.18 Million	+16.27%
2021-12-31	₩259.14 Billion ≈ $175.61 Million	+9.26%
2020-12-31	₩237.18 Billion ≈ $160.74 Million	+2.44%
2019-12-31	₩231.54 Billion ≈ $156.91 Million	+6.23%
2018-12-31	₩217.97 Billion ≈ $147.71 Million	-7.54%
2017-12-31	₩235.74 Billion ≈ $159.76 Million	--

About Jeil Pharmaceutical Co Ltd

KO:271980 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$138.25 Million

₩204.00 Billion KRW

Market Cap Rank

#17938 Global

#875 in Korea

Share Price

₩14000.00

Change (1 day)

-1.82%

52-Week Range

₩12000.00 - ₩17390.00

All Time High

₩104611.38